Compare Mutual Funds
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹200
-
Expense Ratio
2.36
-
NAV
₹31.33
-
Fund Started
08 Feb 2019
-
Fund Size
₹78.30 Cr
-
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
-
1 Year
0.77%
-
3 Year
20.05%
-
5 Year
10.49%
-
Equity
96.18%
-
Cash
3.82%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.77% |
Torrent Pharmaceuticals Ltd. | 7.08% |
Apollo Hospitals Enterprise Ltd. | 6.84% |
Aurobindo Pharma Ltd. | 5.21% |
Divi's Laboratories Ltd. | 4.68% |
Fortis Healthcare Ltd. | 4.37% |
Onesource Specialty Pharma Ltd. | 4.17% |
Neuland Laboratories Ltd. | 3.97% |
Piramal Pharma Ltd. | 3.94% |
Ipca Laboratories Ltd. | 3.40% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
-
Launch Date
08 Feb 2019
-
